Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Go back to Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
(NASDAQ: RANI) Delayed: 0.77 --0 (-0%)
Previous Close $0.77    52 Week High
Open $0.77    52 Week Low
Day High $0.77    P/E N/A 
Day Low $0.77    EPS
Volume 1,059